Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kerstin Pfister

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
Antimicrobial Agents and Chemotherapy|January 11, 2007
Diminished ciprofloxacin-induced chondrotoxicity by supplementation with magnesium and vitamin E in immature ratsKerstin Pfister, Dago Mazur, Jürgen Vormann, et al.
Deutsches Arzteblatt International|April 28, 2022
Extragenital Endometriosis in the Differential Diagnosis of Non- Gynecological DiseasesStefan Lukac, Marinus Schmid, Kerstin Pfister, et al.
Geburtshilfe Und Frauenheilkunde|June 13, 2025
Correction: Adjuvant Targeted Treatment of Early Hormone Receptor-positive HER2-negative Breast Cancer: Olaparib, Abemaciclib or Ribociclib - Which One, How and For Whom?Stefan Lukac, Kerstin Pfister, Henning Schäffler, et al.
Women'S Health (London, England)|May 31, 2024
Leveraging web search data in Germany to identify unmet needs of contraceptives on a population-based level: A longitudinal retrospective studyCharlotte Steiner, Hannah Wecker, Linda Tizek, et al.
International Journal of Gynaecology and Obstetrics: the Official Organ of the International Federation of Gynaecology and Obstetrics|October 5, 2023
Three-dimensional model for improvement of endometriosis care (3D-E)Stefan Lukac, Katharina Hancke, Wolfgang Janni, et al.
Geburtshilfe Und Frauenheilkunde|June 13, 2025
Adjuvant Targeted Treatment of Early Hormone Receptor-positive HER2-negative Breast Cancer: Olaparib, Abemaciclib or Ribociclib - Which One, How and For Whom?Stefan Lukac, Kerstin Pfister, Henning Schäffler, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|November 3, 2024
Eco-logistical comparison of non-radioactive seeds and the wire-guided localization for intraoperative detection of breast lesionsStefan Lukac, Elena Leinert, Thorsten Kühn, et al.
Archives of Gynecology and Obstetrics|February 19, 2026
Age-dependent differences in survival of patients with early breast cancer: analysis of SUCCESS A, B, C trialsStefan Lukac, Davut Dayan, Wolfgang Janni, et al.
Archives of Gynecology and Obstetrics|July 17, 2023
Evaluating ChatGPT as an adjunct for the multidisciplinary tumor board decision-making in primary breast cancer casesStefan Lukac, Davut Dayan, Visnja Fink, et al.
Breast Care (Basel, Switzerland)|May 7, 2025
Do We Need Anthracyclines for Elderly Patients with Triple-Negative Breast Cancer?Stefan Lukac, Visnja Fink, Thomas W P Friedl, et al.
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Antimicrobial Agents and Chemotherapy|January 11, 2007
Diminished ciprofloxacin-induced chondrotoxicity by supplementation with magnesium and vitamin E in immature ratsKerstin Pfister, Dago Mazur, Jürgen Vormann, et al.
Deutsches Arzteblatt International|April 28, 2022
Extragenital Endometriosis in the Differential Diagnosis of Non- Gynecological DiseasesStefan Lukac, Marinus Schmid, Kerstin Pfister, et al.
Geburtshilfe Und Frauenheilkunde|June 13, 2025
Correction: Adjuvant Targeted Treatment of Early Hormone Receptor-positive HER2-negative Breast Cancer: Olaparib, Abemaciclib or Ribociclib - Which One, How and For Whom?Stefan Lukac, Kerstin Pfister, Henning Schäffler, et al.
Women'S Health (London, England)|May 31, 2024
Leveraging web search data in Germany to identify unmet needs of contraceptives on a population-based level: A longitudinal retrospective studyCharlotte Steiner, Hannah Wecker, Linda Tizek, et al.
International Journal of Gynaecology and Obstetrics: the Official Organ of the International Federation of Gynaecology and Obstetrics|October 5, 2023
Three-dimensional model for improvement of endometriosis care (3D-E)Stefan Lukac, Katharina Hancke, Wolfgang Janni, et al.
Geburtshilfe Und Frauenheilkunde|June 13, 2025
Adjuvant Targeted Treatment of Early Hormone Receptor-positive HER2-negative Breast Cancer: Olaparib, Abemaciclib or Ribociclib - Which One, How and For Whom?Stefan Lukac, Kerstin Pfister, Henning Schäffler, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|November 3, 2024
Eco-logistical comparison of non-radioactive seeds and the wire-guided localization for intraoperative detection of breast lesionsStefan Lukac, Elena Leinert, Thorsten Kühn, et al.
Archives of Gynecology and Obstetrics|February 19, 2026
Age-dependent differences in survival of patients with early breast cancer: analysis of SUCCESS A, B, C trialsStefan Lukac, Davut Dayan, Wolfgang Janni, et al.
Archives of Gynecology and Obstetrics|July 17, 2023
Evaluating ChatGPT as an adjunct for the multidisciplinary tumor board decision-making in primary breast cancer casesStefan Lukac, Davut Dayan, Visnja Fink, et al.
Breast Care (Basel, Switzerland)|May 7, 2025
Do We Need Anthracyclines for Elderly Patients with Triple-Negative Breast Cancer?Stefan Lukac, Visnja Fink, Thomas W P Friedl, et al.
Pageof 2